Solmeron, Adelai9da D.

HRN: 25-01-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2025
CO-AMOXICLAV 625MG (TAB)
09/06/2025
09/12/2025
ORAL
625mg
BID
Infected Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines